Back
United Therapeutics Stock Price Chart
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right here
Buy
55
UTHR
United Therapeutics
Last Price:
264.33
Seasonality Move:
10.48%
7 Day Trial
ALL ACCESS PASS
$
7
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing selling pressure, which indicates risk of future bearish movement.
United Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 261.71 | Buy |
| 20-day SMA: | 245.96 | Buy |
| 50-day SMA: | 240.58 | Buy |
| 200-day SMA: | 230.54 | Buy |
| 8-day EMA: | 259.44 | Buy |
| 20-day EMA: | 250.28 | Buy |
| 50-day EMA: | 241.19 | Buy |
| 200-day EMA: | 232.35 | Buy |
United Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.99 | Buy |
| Relative Strength Index (14 RSI): | 66.78 | Buy |
| Chaikin Money Flow: | -346377 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (231.68 - 256.44) | Buy |
| Bollinger Bands (100): | (216.92 - 243.9) | Buy |
United Therapeutics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for United Therapeutics Stock
Is United Therapeutics Stock a Buy?
- United Therapeutics share price is 264.27 while UTHR 8-day simple moving average is 261.71, which is a Buy signal.
- The stock price of UTHR is 264.27 while United Therapeutics 20-day SMA is 245.96, which makes it a Buy.
- United Therapeutics 50-day simple moving average is 240.58 while UTHR share price is 264.27, making it a Buy technically.
- UTHR stock price is 264.27 and United Therapeutics 200-day simple moving average is 230.54, creating a Buy signal.
UTHR Technical Analysis vs Fundamental Analysis
Buy
55
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a Buy
The current United Therapeutics [UTHR] share price is $264.27. The Score for UTHR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
United Therapeutics Stock Info
Market Cap:
11.72B
Price in USD:
264.27
Share Volume:
391.67K
United Therapeutics 52-Week Range
52-Week High:
269.81
52-Week Low:
204.44
Buy
55
United Therapeutics (UTHR)
is a Buy
United Therapeutics Share Price Forecast
-
What is the United Therapeutics stock price today?
The United Therapeutics stock price is 264.27 USD today. -
Will UTHR stock go up or go down?
United Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is United Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics is not overvalued.
Is United Therapeutics Stock a Buy?
- United Therapeutics share price is 264.27 while UTHR 8-day exponential moving average is 259.44, which is a Buy signal.
- The stock price of UTHR is 264.27 while United Therapeutics 20-day EMA is 250.28, which makes it a Buy.
- United Therapeutics 50-day exponential moving average is 241.19 while UTHR share price is 264.27, making it a Buy technically.
- UTHR stock price is 264.27 and United Therapeutics 200-day simple moving average is 232.35, creating a Buy signal.
Fundamental Analysis of United Therapeutics
Is United Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.46 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.83 per share, and an increase next year of $1.72 per share.
Technical Analysis of United Therapeutics
Should I short United Therapeutics stock?
- UTHR Moving Average Covergence Divergence (MACD) indicator is 7.99, suggesting United Therapeutics is a Buy
- United Therapeutics Relative Strength Index (RSI) is 66.78, which suggest United Therapeutics is overbought
- The Bollinger Bands (25) for United Therapeutics is (231.68 - 256.44), which suggest United Therapeutics is a Buy
- The Bollinger Bands (100) for United Therapeutics is (216.92 - 243.9), which suggest United Therapeutics is a Buy
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.